TruScan RM

Article

Thermo Scientific portable solutions deliver specialized identification and analysis of raw materials for the highly regulated global pharmaceutical industry.

Thermo Scientific portable solutions deliver specialized identification and analysis of raw materials for the highly regulated global pharmaceutical industry.

With greater than 650 GMP facility installations worldwide, we’ve successfully implemented our solutions into the top pharmaceutical companies and regulatory enforcement agencies worldwide – enabling them to increase productivity and realize a rapid return on their investment.

We are more than the leading provider of portable analytical instruments. We are a true partner, delivering expertise and solutions to improve processes, reduce risk & costs, and achieve competitive advantage.

Developed with in-depth pharmaceutical industry experience, Thermo Scientific handheld analyzers provide manufacturers with a portable solution to achieve quality initiatives throughout the manufacturing process.
The Thermo Scientific TruScan RM, based on Raman spectroscopy, and the Thermo Scientific microPHAZIR RX, based on Near-Infrared spectroscopy, are simple to use and enable on-the-spot, actionable Pass-Fail results within seconds.
 
Both analyzers are 21 CFR part 11 compliant and meet the requirements of global pharmacopeias.  Our handheld solutions are used by 24 of the top 25 global pharmaceutical manufacturers, driving significant time and cost savings. 

Thermo Scientific is part of Thermo Fisher Scientific, the world leader in serving science.

 

Thermo Scientific – Portable Analytical Instruments

Website: www.thermoscientific.com/quality

E-mail: sales.chemid@thermofisher.com

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content